Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
DARPA Supports Research on Pollen for Oral Vaccine Delivery Medical Countermeasures November 28, 2012 …
Army Dengue Vaccine Trial Supported by State University of New York Industry News November 28, 2012 …
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Open Access Initiative Helps Neglected Tropical Disease Drug Effort Industry News November 13, 2012 …
NIH, CDC Small Business Innovation for Medical Countermeasures Contracts + Grants November 12, 2012 …
DTRA to Advance Nanostructured Therapeutics for Chem-Bio Defense Contracts + Grants October 22, 2012 …
